Document is current
Any future updates will be listed below
-
Authors
Fischer, David S. https://orcid.org/0000-0002-1293-7656
Villanueva, Martin A. https://orcid.org/0000-0002-7630-1403
Winter, Peter S. https://orcid.org/0000-0002-6557-3219
Shalek, Alex K. https://orcid.org/0000-0001-5670-8778
- License Information
-
More Information
Article History
Accepted: 29 January 2025
First Online: 10 March 2025
Competing interests
: A.K.S. reports compensation for consulting and/or SAB membership from Honeycomb Biotechnologies, Cellarity, Ochre Bio, Bio-Rad Laboratories, Relation Therapeutics, IntrECate biotherapeutics, Parabalis Medicines, Quotient Therapeutics, Passkey Therapeutics, Danaher and Dahlia Biosciences unrelated to this work. P.S.W. reports compensation for consulting/speaking from Engine Ventures and AbbVie unrelated to this work. The other authors declare no competing interests.
